MARKET RADAR
SENSEX     NIFTY      Refresh
Aurobindo Pharma Profit & Loss account, Aurobindo Pharma Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Aurobindo Pharma
Aurobindo Pharma
BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 25, 17:00
116.80
1.45 (1.26%)
VOLUME 205,295
LIVE
NSE
May 25, 17:00
117.00
1.55 (1.34%)
VOLUME 1,426,588
Previous Years »

Profit & Loss account of Aurobindo Pharma

 ------------------- in Rs. Cr. -------------------
Mar '11 Mar '10 Mar '09 Mar '08 Mar '07
12 mths 12 mths 12 mths 12 mths 12 mths
Income
Sales Turnover 4,229.99 3,319.60 2,885.25 2,351.12 1,979.76
Excise Duty 99.54 67.54 90.35 116.49 103.67
Net Sales 4,130.45 3,252.06 2,794.90 2,234.63 1,876.09
Other Income 17.61 112.22 -193.56 155.32 95.05
Stock Adjustments 136.37 147.48 28.94 31.18 72.47
Total Income 4,284.43 3,511.76 2,630.28 2,421.13 2,043.61
Expenditure
Raw Materials 2,487.19 2,010.02 1,750.75 1,491.36 1,314.44
Power & Fuel Cost 184.55 135.48 118.32 96.32 82.72
Employee Cost 303.60 232.62 177.18 148.70 112.88
Other Manufacturing Expenses 79.03 59.14 46.08 43.04 39.22
Selling and Admin Expenses 207.53 186.29 195.12 120.96 97.66
Miscellaneous Expenses 37.22 18.71 19.52 47.90 22.80
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 3,299.12 2,642.26 2,306.97 1,948.28 1,669.72
Mar '11 Mar '10 Mar '09 Mar '08 Mar '07
12 mths 12 mths 12 mths 12 mths 12 mths
Operating Profit 967.70 757.28 516.87 317.53 278.84
PBDIT 985.31 869.50 323.31 472.85 373.89
Interest 55.02 62.58 81.20 59.01 76.07
PBDT 930.29 806.92 242.11 413.84 297.82
Depreciation 125.04 95.46 82.41 74.60 71.84
Other Written Off 0.00 0.00 0.00 0.00 0.00
Profit Before Tax 805.25 711.46 159.70 339.24 225.98
Extra-ordinary items -0.95 -1.61 4.29 5.60 3.04
PBT (Post Extra-ord Items) 804.30 709.85 163.99 344.84 229.02
Tax 210.50 184.09 35.45 54.06 -0.16
Reported Net Profit 593.80 525.76 128.54 290.78 229.08
Total Value Addition 811.93 632.24 556.22 456.92 355.28
Preference Dividend 0.00 0.00 0.00 0.00 0.00
Equity Dividend 58.72 27.74 24.20 17.57 13.34
Corporate Dividend Tax 9.64 4.67 4.11 2.98 2.27
Per share data (annualised)
Shares in issue (lakhs) 2,911.21 557.29 537.65 537.65 533.49
Earning Per Share (Rs) 20.40 94.34 23.91 54.08 42.94
Equity Dividend (%) 200.00 100.00 90.00 65.00 50.00
Book Value (Rs) 88.27 343.51 245.67 227.02 174.19
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm

  • News
  • Results
  • Estimates
  • Analysis

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
Quick Links for aurobindopharma
Related Searches aurobindopharma Stock Price, Aurobindo%20Pharm Stock Quote, Aurobindo%20Pharm Results , Aurobindo%20Pharm News .. More »
Follow moneycontrol.com

Facebook Twitter RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News | Markets | IPO | Technicals | Mutual Fund | Commodities | Best Portfolio Manager | Bse Sensex | Bombay Stock Exchange | Share Market Live | Recession 2011 | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | National Stock Exchange | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Property rates in India | Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |  Intuit Money Manager | RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget  | Financial Glossary  |  Message Board | Moneybhai | Connect.in.com | Business Yellow Pages | India's Premiere Technology Guide |  History India | Davos  | RIL | Bharti Airtel | Air India | Anil Ambani | Pranab Mukherjee | BSE Sensex | Rajat Gupta | Securities and Exchange Board of India | Nitish Kumar | Mamata Banerjee
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.